Strawich E, Glimcher M J
Department of Orthopedic Surgery, Harvard Medical School, Children's Hospital, Boston 02115.
Eur J Biochem. 1990 Jul 20;191(1):47-56. doi: 10.1111/j.1432-1033.1990.tb19092.x.
The major enamelin protein component present in EDTA or EDTA/guanidine hydrochloride extracts of developing bovine enamel has a molecular mass of about 67 kDa; it has an amino acid composition similar to that of bovine serum albumin and reacts with polyclonal and monoclonal antibodies to albumin. Two-dimensional separation of the components in the enamelin extract by isoelectric focusing and SDS/PAGE reveal that the major approximately 67-kDa component and almost all of the minor Coomassie-staining protein components of approximately 67 kDa, as well as many of the other minor components with different molecular masses, also react with polyclonal and monoclonal antialbumin. The approximately 67-kDa band eluted after SDS/PAGE, as well as the major approximately 67-kDa spots eluted after two-dimensional separation, were found to have N-terminal amino acid sequences identical to that of bovine serum albumin. Albumin accounted for at least 70-80% of the total protein content of the enamelin extract and was essentially the only protein in the approximately 67-kDa component. The serum proteins alpha-2 HS glycoprotein, gamma-globulin and fetuin, and the proline-rich salivary protein termed P-B were also identified in the enamelin extract. The serum proteins and the salivary protein account for greater than 95% of the proteins in the enamelin extracts. Of the remaining very small amounts of non-serum or salivary protein isolated from the enamelin extracts, three minor components were isolated which had N-terminal amino acid sequences which were not similar to any known protein in the protein sequence data base and could therefore conceivably be true 'enamelins' synthesized by ameloblasts. One additional protein had the first five N-terminal amino acids and residue 8 of amelogenin, residues 6 and 7 being different from those of amelogenin. Two other very minor protein components had amino acid compositions distinct from the amelogenins and the serum proteins, but were N-terminally blocked on attempted sequencing. None of the components in the neutral soluble low-ionic-strength extract or in the 4 M guanidine hydrochloride extract, both of which consist principally of amelogenins, immunoreacted with anti-albumin or with any of the antibodies to other serum proteins and fetuin, despite the fact that the amelogenin extracts also contain non-amelogenin proteins. On the basis of the data presented, studies employing antibodies to the so-called enamelin proteins and hypotheses as to their molecular conformation, their roles as evolutionary markers, or their positive role in mineralization should be reconsidered and reviewed.
发育中的牛牙釉质经乙二胺四乙酸(EDTA)或EDTA/盐酸胍提取后,其主要的釉原蛋白成分分子量约为67 kDa;它的氨基酸组成与牛血清白蛋白相似,能与抗白蛋白的多克隆和单克隆抗体发生反应。通过等电聚焦和SDS/PAGE对釉原蛋白提取物中的成分进行二维分离,结果显示,主要的约67 kDa成分以及几乎所有约67 kDa的次要考马斯亮蓝染色蛋白成分,还有许多其他不同分子量的次要成分,也能与多克隆和单克隆抗白蛋白抗体发生反应。SDS/PAGE后洗脱的约67 kDa条带,以及二维分离后洗脱的主要约67 kDa斑点,其N端氨基酸序列与牛血清白蛋白相同。白蛋白占釉原蛋白提取物总蛋白含量的至少70 - 80%,并且基本上是约67 kDa成分中的唯一蛋白质。在釉原蛋白提取物中还鉴定出了血清蛋白α-2 HS糖蛋白、γ-球蛋白和胎球蛋白,以及富含脯氨酸的唾液蛋白P-B。血清蛋白和唾液蛋白占釉原蛋白提取物中蛋白质的95%以上。从釉原蛋白提取物中分离出的其余极少量非血清或唾液蛋白中,有三种次要成分,其N端氨基酸序列与蛋白质序列数据库中任何已知蛋白质均不相似,因此可以想象它们可能是成釉细胞合成的真正“釉原蛋白”。还有一种蛋白质具有釉原蛋白的前五个N端氨基酸和第8位残基,第6和7位残基与釉原蛋白不同。另外两种非常次要的蛋白质成分,其氨基酸组成与釉原蛋白和血清蛋白不同,但在测序时N端被封闭。中性可溶性低离子强度提取物或4 M盐酸胍提取物中的成分,主要由釉原蛋白组成,尽管釉原蛋白提取物中也含有非釉原蛋白,但它们均未与抗白蛋白或其他血清蛋白及胎球蛋白的任何抗体发生免疫反应。基于所呈现的数据,使用针对所谓釉原蛋白的抗体以及关于其分子构象、作为进化标记的作用或在矿化中的积极作用的假设的研究,应重新考虑和审视。